$ORC
Orchid Island Capital, Inc. Stock $orc

$orc Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000127547717000069 Filed on August 01, 2017

Income Statement

Concept	2017 Q3	2017 Q2	2016 Q2
Revenue	$38.97M	$34.58M	$19.24M
YoY Change	74.32%	79.77%	14.82%
Cost Of Revenue	$14.17M	$10.16M	$4.280M
YoY Change	181.71%	137.38%	65.89%
Gross Profit	$16.55M	-$8.180M	$7.650M
YoY Change	-23.91%	-206.93%	-513.51%
Gross Profit Margin	42.46%	-23.66%	39.77%
Selling, General & Admin	$2.899M	$2.862M	$2.134M
YoY Change	27.65%	34.11%	6.65%
% of Gross Profit	17.52%		27.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.899M	$2.862M	$2.134M
YoY Change	27.65%	34.11%	6.65%
Operating Profit	$13.65M	-$11.04M	$5.516M
YoY Change	-29.92%	-300.18%	-243.24%
Interest Expense	$12.64M	$8.763M	$3.330M
YoY Change	217.62%	163.15%	112.51%
% of Operating Profit	92.58%		60.37%
Other Income/Expense, Net	$959.0K	$1.074M	$860.0K
YoY Change	8.61%	24.88%	20.62%
Pretax Income	$15.18M	-$9.640M	$6.460M
YoY Change	-26.06%	-249.23%	-328.27%
Income Tax
% Of Pretax Income
Net Earnings	$15.18M	-$9.643M	$6.463M
YoY Change	-26.03%	-249.2%	-328.21%
Net Earnings / Revenue	38.96%	-27.89%	33.6%
Basic Earnings Per Share	$0.33	-$0.26	$0.29
Diluted Earnings Per Share	$0.33	-$0.26	$0.29
COMMON SHARES
Basic Shares Outstanding	45.30M shares	34.88M shares	21.78M shares
Diluted Shares Outstanding		37.21M shares	21.92M shares

Balance Sheet

Concept	2017 Q3	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$161.7M	$199.8M	$65.40M
YoY Change	45.81%	205.5%	-34.93%
Cash & Equivalents	$161.7M	$199.8M	$65.35M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$177.1M	$214.2M	$74.20M
YoY Change	19.74%	188.68%	-32.05%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.930B	$3.738B	$2.223B
YoY Change	57.12%	68.12%	2.23%
Other Assets	$12.00M	$6.500M	$3.800M
YoY Change	42.86%	71.05%	-83.55%
Total Long-Term Assets	$3.967B	$3.769B	$2.243B
YoY Change	57.4%	68.02%	2.02%
TOTAL ASSETS
Total Short-Term Assets	$177.1M	$214.2M	$74.20M
Total Long-Term Assets	$3.967B	$3.769B	$2.243B
Total Assets	$4.144B	$3.983B	$2.317B
YoY Change	55.31%	71.89%	0.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$800.0K	$700.0K	$400.0K
YoY Change	60.0%	75.0%	-20.0%
Accrued Expenses	$4.800M	$2.200M	$1.400M
YoY Change	152.63%	57.14%	133.33%
Deferred Revenue
YoY Change
Short-Term Debt	$3.710B	$3.279B	$2.061B
YoY Change	61.44%	59.09%	2.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.722B	$3.561B	$2.067B
YoY Change	56.86%	72.31%	2.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$8.000M	$3.400M	$6.500M
YoY Change	515.38%	-47.69%	712.5%
Total Long-Term Liabilities	$8.000M	$3.400M	$6.500M
YoY Change	515.38%	-47.69%	712.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.722B	$3.561B	$2.067B
Total Long-Term Liabilities	$8.000M	$3.400M	$6.500M
Total Liabilities	$3.730B	$3.565B	$2.073B
YoY Change	57.11%	71.92%	2.47%
SHAREHOLDERS EQUITY
Retained Earnings	$0.00		$0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$414.4M	$418.2M	$243.7M
YoY Change
Total Liabilities & Shareholders Equity	$4.144B	$3.983B	$2.317B
YoY Change	55.31%	71.89%	0.41%

Cashflow Statement

Concept	2017 Q3	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$15.18M	-$9.643M	$6.463M
YoY Change	-26.03%	-249.2%	-328.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$19.72M	$6.280M	$9.080M
YoY Change	16.76%	-30.84%	-28.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$470.7M	-$222.2M	-$126.8M
YoY Change	92.12%	75.32%	-78.91%
Cash From Investing Activities	-$470.7M	-$222.2M	-$126.8M
YoY Change	92.12%	75.32%	-78.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	412.6M	322.9M	118.7M
YoY Change	54.31%	172.11%	-80.57%
NET CHANGE
Cash From Operating Activities	19.72M	6.280M	9.080M
Cash From Investing Activities	-470.7M	-222.2M	-126.8M
Cash From Financing Activities	412.6M	322.9M	118.7M
Net Change In Cash	-38.38M	106.9M	990.0K
YoY Change	-197.76%	10702.02%	-95.57%
FREE CASH FLOW
Cash From Operating Activities	$19.72M	$6.280M	$9.080M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-45490000	USD
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32962919	shares
CY2017Q2	orc	Mortgage Backed Securities At Fair Value Unpledged MortgageBackedSecuritiesAtFairValueUnpledged	286880000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3138694000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	690000	USD
CY2016Q4	orc	Repurchaseagreementcashcollateral Repurchaseagreementcashcollateral	10835000	USD
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2010-08-17
CY2016Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	1982000	USD
CY2017Q2	orc	Repurchase Agreement Amount At Risk RepurchaseAgreementAmountAtRisk	190600000	USD
CY2017Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2168000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	418174000	USD
CY2017Q2	orc	Securities Acquisitions Settled In Later Period SecuritiesAcquisitionsSettledInLaterPeriod	273689000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum	0.1	pure
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20950000	USD
	dei	Entity Registrant Name EntityRegistrantName	Orchid Island Capital, Inc.
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28902000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	424914000	USD
	orc	Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading	3692066000	USD
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q2	orc	Net Amount Of Liabilities NetAmountOfLiabilities	0	USD
	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	25243560000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	342000	USD
CY2017Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	195300000	USD
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	212000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2817000	USD
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45303821	shares
CY2017Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	421000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	332779000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	124000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	14028116000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	3564714000	USD
CY2017Q2	orc	Federal Deposit Insurance Corporation Per Depositor Limit FederalDepositInsuranceCorporationPerDepositorLimit	250000	USD
CY2016Q4	orc	Mortgage Backed Securities After Five Through Ten Years Fair Value MortgageBackedSecuritiesAfterFiveThroughTenYearsFairValue	277000	USD
CY2017Q2	orc	Weighted Average Borrowing Rate WeightedAverageBorrowingRate	0.013	pure
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	56000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	122857000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	orc	Proceeds From Net Tba Settlements ProceedsFromNetTbaSettlements	-5591000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	10365000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	19865000	USD
CY2016Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1826000	USD
CY2016Q4	orc	Mortgage Backed Securities At Fair Value Unpledged MortgageBackedSecuritiesAtFairValueUnpledged	49884000	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	10365000	USD
CY2016Q4	us-gaap	Mortgage Backed Securities Available For Sale Fair Value Disclosure MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure	3022174000	USD
CY2017Q2	orc	Gross Amount Of Recognized Liabilties GrossAmountOfRecognizedLiabilties	3281168000	USD
CY2016Q4	orc	Mortgage Backed Securities After One Through Five Years Fair Value MortgageBackedSecuritiesAfterOneThroughFiveYearsFairValue	157000	USD
CY2017Q2	us-gaap	Other Liabilities OtherLiabilities	657000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	2805915000	USD
CY2017Q2	orc	Repurchaseagreementcashcollateral Repurchaseagreementcashcollateral	6540000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7193000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	0	shares
CY2017Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2712000	USD
CY2017Q2	orc	Mortgage Backed Securities After One Through Five Years Fair Value MortgageBackedSecuritiesAfterOneThroughFiveYearsFairValue	77000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1982000	USD
	orc	Unrealized Gains Swaps UnrealizedGainsSwaps	-3689000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	187500000	USD
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017Q2	us-gaap	Derivative Assets DerivativeAssets	10613000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	213000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7193000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199796000	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q2	orc	Collateral Held On Repurchase Agreements CollateralHeldOnRepurchaseAgreements	3464666000	USD
CY2016Q4	orc	Collateral Held On Repurchase Agreements CollateralHeldOnRepurchaseAgreements	2970880000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	3220000	USD
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Assets Assets	3982888000	USD
CY2017Q2	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	3281168000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	10613000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73475000	USD
CY2017Q2	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-3271916000	USD
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	330000	USD
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q2	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	3278456000	USD
	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2010-11-24
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	3000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-477372000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	203000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2563000	USD
	orc	Stock Repurchase Program Weighted Average Price Cumulative StockRepurchaseProgramWeightedAveragePriceCumulative	8.92
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	578706000	USD
	orc	Payments For Securities Sold Under Agreements To Repurchase PaymentsForSecuritiesSoldUnderAgreementsToRepurchase	24758809000	USD
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001518621
	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	1327500000	USD
	orc	Stock Repurchase Program Cumulative Shares Repurchased StockRepurchaseProgramCumulativeSharesRepurchased	1216243	shares
CY2016Q4	us-gaap	Interest Receivable InterestReceivable	11512000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	332449000	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	orc	Mortgage Backed Securities After Ten Years Fair Value MortgageBackedSecuritiesAfterTenYearsFairValue	3737552000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2491000	USD
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22431000	shares
	orc	Swaption Gain SwaptionGain	0	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	-29463000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	196000	USD
CY2017Q2	us-gaap	Mortgage Backed Securities Available For Sale Fair Value Disclosure MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure	3737827000	USD
	dei	Entity Incorporation State Country Name EntityIncorporationStateCountryName	MD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	USD
CY2016Q4	orc	Mortgage Backed Securities After Ten Years Fair Value MortgageBackedSecuritiesAfterTenYearsFairValue	3021740000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	122857000	USD
CY2017Q2	orc	Gross Amounts Of Cash Posted Not Offset In Balance Sheet GrossAmountsOfCashPostedNotOffsetInBalanceSheet	-9252000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	30628000	USD
CY2017Q2	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	2712000	USD
	orc	Proceeds From Securities Sold Under Agreements To Repurchase ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase	14290130000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-21000	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
CY2016Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	566000	USD
CY2016Q2	orc	Securities Acquisitions Settled In Later Period SecuritiesAcquisitionsSettledInLaterPeriod	4276000	USD
	orc	Proceeds From Net Tba Settlements ProceedsFromNetTbaSettlements	-1598000	USD
	us-gaap	Payments For Federal Home Loan Bank Advances PaymentsForFederalHomeLoanBankAdvances	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	orc	Required Annual Distribution Of Taxable Income RequiredAnnualDistributionOfTaxableIncome	0.9	pure
CY2017Q2	us-gaap	Interest Receivable InterestReceivable	14366000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	549000	USD
	orc	Gains On Tba Securities GainsOnTbaSecurities	-2384000	USD
CY2017Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	453000	USD
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-321000	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-704000	USD
	us-gaap	Interest Paid InterestPaid	15136000	USD
	orc	Amortization Of Equity Awards AmortizationOfEquityAwards	163000	USD
	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	109412000	USD
CY2017Q2	orc	Gross Amount Of Liabilties Offset In The Balance Sheet GrossAmountOfLiabiltiesOffsetInTheBalanceSheet	0	USD
	us-gaap	Gain Loss On Investments Excluding Other Than Temporary Impairments GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments	12302000	USD
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	dei	Trading Symbol TradingSymbol	ORC
CY2016Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	2793705000	USD
	orc	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading	155303000	USD
CY2017Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2000000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	62684000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6591000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4000000	shares
CY2016Q4	orc	Weighted Average Borrowing Rate WeightedAverageBorrowingRate	0.01	pure
	orc	Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading	3064979000	USD
CY2016Q4	orc	Mortgage Backed Securities At Fair Value Pledged As Collateral MortgageBackedSecuritiesAtFairValuePledgedAsCollateral	2972290000	USD
	orc	Stock Repurchase Program Authorization Date StockRepurchaseProgramAuthorizationDate	2015-07-29
CY2017Q2	orc	Unpledged Unsettled Securities Purchases UnpledgedUnsettledSecuritiesPurchases	272300000	USD
CY2017Q2	orc	Mortgage Backed Securities At Fair Value Pledged As Collateral MortgageBackedSecuritiesAtFairValuePledgedAsCollateral	3450947000	USD
	orc	Stock Repurchase Program Cumulative Cost StockRepurchaseProgramCumulativeCost	10800000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3982888000	USD
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32962919	shares
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
	us-gaap	Interest Paid InterestPaid	6100000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	23902000	USD
CY2016Q4	us-gaap	Assets Assets	3138694000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	218000	USD
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45299812	shares
CY2017Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	6342000	USD
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	4616000	USD
	orc	Cash Cash Equivalents And Restricted Cash Period Increase Decrease CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease	125236000	USD
	orc	Cash Cash Equivalents And Restricted Cash Period Increase Decrease CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease	14377000	USD
CY2016Q4	orc	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	94425000	USD
CY2015Q4	orc	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	69959000	USD
CY2017Q2	orc	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	219661000	USD
CY2016Q2	orc	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	84336000	USD
CY2017Q2	orc	Federal Home Loan Bank Stock Dividends FederalHomeLoanBankStockDividends	0	USD
CY2017Q2	orc	Net Portfolio Income NetPortfolioIncome	-6781000	USD
CY2016Q2	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	3330000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15905000	USD
CY2016Q4	orc	Unsettled Purchases UnsettledPurchases	0	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	66890000	USD
	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	15478000	USD
CY2017Q2	orc	Gross Amount Of Recognized Assets GrossAmountOfRecognizedAssets	10613000	USD
CY2017Q2	orc	Gross Amount Of Assets Offset In The Balance Sheet GrossAmountOfAssetsOffsetInTheBalanceSheet	0	USD
CY2017Q2	orc	Net Amount Of Assets Presented In The Balance Sheet NetAmountOfAssetsPresentedInTheBalanceSheet	10613000	USD
CY2017Q2	orc	Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet	0	USD
CY2017Q2	orc	Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet	-120000	USD
CY2017Q2	orc	Net Amount Of Assets NetAmountOfAssets	10493000	USD
CY2016Q4	orc	Gross Amount Of Recognized Assets GrossAmountOfRecognizedAssets	10365000	USD
CY2016Q4	orc	Gross Amount Of Assets Offset In The Balance Sheet GrossAmountOfAssetsOffsetInTheBalanceSheet	0	USD
CY2016Q4	orc	Net Amount Of Assets Presented In The Balance Sheet NetAmountOfAssetsPresentedInTheBalanceSheet	10365000	USD
CY2016Q4	orc	Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet	0	USD
CY2016Q4	orc	Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet	-63000	USD
CY2016Q4	orc	Net Amount Of Assets NetAmountOfAssets	10302000	USD
CY2016Q4	orc	Gross Amount Of Recognized Liabilties GrossAmountOfRecognizedLiabilties	2795687000	USD
CY2016Q4	orc	Gross Amount Of Liabilties Offset In The Balance Sheet GrossAmountOfLiabiltiesOffsetInTheBalanceSheet	0	USD
CY2016Q4	orc	Net Amount Of Liabilities Presented In The Balance Sheet NetAmountOfLiabilitiesPresentedInTheBalanceSheet	2795687000	USD
CY2016Q4	orc	Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet	-2782870000	USD
CY2016Q4	orc	Gross Amounts Of Cash Posted Not Offset In Balance Sheet GrossAmountsOfCashPostedNotOffsetInBalanceSheet	-12485000	USD
CY2016Q4	orc	Net Amount Of Liabilities NetAmountOfLiabilities	332000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	61238	shares
CY2017Q2	orc	Unsettled Purchases UnsettledPurchases	273689000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	51412000	USD
	orc	Realized Gains On Investments RealizedGainsOnInvestments	2585000	USD
	orc	Unrealized Gains On Investments UnrealizedGainsOnInvestments	-32048000	USD
CY2016Q2	orc	Realized Gains On Investments RealizedGainsOnInvestments	10000	USD
CY2016Q2	orc	Unrealized Gains On Investments UnrealizedGainsOnInvestments	4262000	USD
CY2016Q2	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-11591000	USD
CY2016Q2	orc	Federal Home Loan Bank Stock Dividends FederalHomeLoanBankStockDividends	11000	USD
	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-23861000	USD
	orc	Federal Home Loan Bank Stock Dividends FederalHomeLoanBankStockDividends	0	USD
	orc	Net Portfolio Income NetPortfolioIncome	-1912000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	39701000	USD
	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	6649000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	33052000	USD
	orc	Realized Gains On Investments RealizedGainsOnInvestments	4253000	USD
	orc	Unrealized Gains On Investments UnrealizedGainsOnInvestments	8049000	USD
	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-39181000	USD
	orc	Federal Home Loan Bank Stock Dividends FederalHomeLoanBankStockDividends	14000	USD
	orc	Net Portfolio Income NetPortfolioIncome	6187000	USD
CY2017Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	34579000	USD
CY2017Q2	us-gaap	Repurchase Agreements Interest Expense Amount RepurchaseAgreementsInterestExpenseAmount	8763000	USD
CY2017Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	25816000	USD
CY2017Q2	orc	Realized Gains On Investments RealizedGainsOnInvestments	3935000	USD
CY2017Q2	orc	Unrealized Gains On Investments UnrealizedGainsOnInvestments	-17090000	USD
CY2017Q2	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-19442000	USD
CY2016Q2	orc	Net Portfolio Income NetPortfolioIncome	8597000	USD
	orc	Management Fees ManagementFees	2702000	USD
	orc	Management Fees ManagementFees	1916000	USD
CY2017Q2	orc	Management Fees ManagementFees	1400000	USD
CY2016Q2	orc	Management Fees ManagementFees	945000	USD
	orc	Allocated Overhead AllocatedOverhead	756000	USD
	orc	Allocated Overhead AllocatedOverhead	626000	USD
CY2017Q2	orc	Allocated Overhead AllocatedOverhead	388000	USD
CY2016Q2	orc	Allocated Overhead AllocatedOverhead	329000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	385000	USD
	orc	Directors Fees And Liability Insurance DirectorsFeesAndLiabilityInsurance	508000	USD
	orc	Directors Fees And Liability Insurance DirectorsFeesAndLiabilityInsurance	527000	USD
CY2017Q2	orc	Directors Fees And Liability Insurance DirectorsFeesAndLiabilityInsurance	232000	USD
CY2016Q2	orc	Directors Fees And Liability Insurance DirectorsFeesAndLiabilityInsurance	245000	USD
	us-gaap	Professional Fees ProfessionalFees	389000	USD
	us-gaap	Professional Fees ProfessionalFees	461000	USD
CY2017Q2	us-gaap	Professional Fees ProfessionalFees	219000	USD
CY2016Q2	us-gaap	Professional Fees ProfessionalFees	215000	USD
	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	496000	USD
	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	239000	USD
CY2017Q2	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	265000	USD
CY2016Q2	orc	Direct Reit Operating Expenses DirectReitOperatingExpenses	99000	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	200000	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	161000	USD
CY2017Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	140000	USD
CY2016Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	87000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-9643000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6463000	USD
CY2017Q2	orc	Effect Of Weighting EffectOfWeighting	-8089000	shares
CY2016Q2	orc	Effect Of Weighting EffectOfWeighting	-566000	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53550	shares
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5281000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4315000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2862000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2134000	USD
	us-gaap	Profit Loss ProfitLoss	-7193000	USD
	us-gaap	Profit Loss ProfitLoss	1872000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	6463000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	35117364	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	21853949	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37211362	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	21920573	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35117364	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21853949	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37211362	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21920573	shares
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.84
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.84
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2016Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
	orc	Swaption Gain SwaptionGain	36000	USD
	orc	Unrealized Gains Swaps UnrealizedGainsSwaps	-5561000	USD
	orc	Gains On Tba Securities GainsOnTbaSecurities	-1911000	USD
	orc	Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading	1485258000	USD
	us-gaap	Proceeds From Sale Of Federal Home Loan Bank Stock ProceedsFromSaleOfFederalHomeLoanBankStock	3750000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6463000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9643000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1872000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1872000	USD
	orc	Effect Of Weighting EffectOfWeighting	-633000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9643000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2017Q2	orc	Orchid Shares Owned OrchidSharesOwned	1520036	shares
CY2017Q2	orc	Orchid Ownership Percentage OrchidOwnershipPercentage	0.034	pure

Files In Submission

Name	View Source	Status
0001275477-17-000069-index-headers.html	Edgar Link	pending
0001275477-17-000069-index.html	Edgar Link	pending
0001275477-17-000069.txt	Edgar Link	pending
0001275477-17-000069-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image0.jpg	Edgar Link	pending
orc-20170630.xml	Edgar Link	completed
orc-20170630.xsd	Edgar Link	pending
orc-20170630_cal.xml	Edgar Link	unprocessable
orc-20170630_def.xml	Edgar Link	unprocessable
orc-20170630_lab.xml	Edgar Link	unprocessable
orc-20170630_pre.xml	Edgar Link	unprocessable
orc10q20170630.htm	Edgar Link	pending
orc10q20170630x311.htm	Edgar Link	pending
orc10q20170630x312.htm	Edgar Link	pending
orc10q20170630x321.htm	Edgar Link	pending
orc10q20170630x322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORC
Orchid Island Capital, Inc. Stock $orc

2017 Q3 Form 10-Q Financial Statement

#000127547717000069 Filed on August 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC Orchid Island Capital, Inc. Stock $orc

2017 Q3 Form 10-Q Financial Statement

#000127547717000069 Filed on August 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORC
Orchid Island Capital, Inc. Stock $orc